The Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Internaional Open Medial Journal (ISSN: Pending) invites original, high-quality submissions that contribute meaningfully to the fields of medicine, pharmacy, biology, and public health. In order to maintain the quality and consistency of publications, authors must adhere strictly to the following submission guidelines. These comprehensive instructions are designed to support authors at every stage of manuscript preparation, submission, and post-submission processing.
1. Types of Manuscripts Accepted
We welcome a variety of manuscript types that reflect the breadth of cancer research. Authors may submit:
Original Research Articles presenting novel experimental findings or clinical data related to any aspect of cancer science or oncology care.
Review Articles offering critical and comprehensive analyses of existing literature on specific cancer-related topics.
Clinical Case Studies documenting rare or instructive patient cases, treatment responses, or unusual presentations in oncology.
Short Communications reporting preliminary data, emerging hypotheses, or urgent findings that warrant rapid dissemination.
Methodological Papers describing new techniques, diagnostic tools, treatment protocols, or innovations in laboratory or clinical methodology.
Opinion Pieces and Editorials offering commentary on current trends, ethical considerations, or evolving practices in cancer research and treatment.
Each submission must demonstrate clear scientific value, sound methodology, and relevance to the global cancer research community.
2. Manuscript Preparation Requirements
Language and Style
Manuscripts must be written in clear, fluent, and grammatically correct English. Authors whose first language is not English are advised to seek professional editing services prior to submission. Clarity, precision, and scientific objectivity are essential.
Format and Structure
Files should be submitted in Microsoft Word format (.doc or .docx).
Use standard 12-point font (Times New Roman or Arial).
Double spacing must be applied throughout the manuscript, including references, figure legends, and tables.
Set 1-inch margins on all sides.
All pages should be numbered consecutively at the bottom right corner.
Title
The title should be specific, concise, and reflective of the main findings or theme of the manuscript. Avoid abbreviations and generic terms. The length should not exceed 15 words.
Abstract
All submissions must include an abstract of 150 to 250 words. The abstract should clearly summarize the study’s background, objectives, methodology, key results, and conclusions. Abstracts must be self-contained and informative for readers unfamiliar with the full text.
Keywords
Authors must provide four to six keywords relevant to the manuscript. These keywords improve discoverability and should reflect core concepts such as “cancer therapy,” “tumor microenvironment,” “oncogenic pathways,” “clinical oncology,” “biomarkers,” “immunotherapy,” and other subject-specific terms.
Main Body Sections
Original research articles should typically be structured under the following standard sections:
Introduction: State the problem, review relevant literature, and clearly define the research question or hypothesis.
Materials and Methods: Describe in detail the experimental design, patient selection (if applicable), laboratory procedures, data analysis techniques, and ethical approvals.
Results: Present findings logically using tables, figures, and clear text. Avoid interpretation in this section.
Discussion: Interpret the findings in the context of existing literature, explain implications, discuss limitations, and suggest directions for future research.
Conclusion: Offer a summary of the key outcomes and their potential significance in cancer research or practice.
Review articles may adopt a thematic structure instead of strict IMRaD formatting but should maintain coherence and logical progression.
3. References
All references must adhere to the APA citation style both in-text and in the reference list.
In-text citation examples:
(Smith & Brown, 2022) or (Jones, 2019)
Reference list example:
Smith, J., & Brown, R. (2022). Advances in breast cancer genomics. Cancer Biology Journal, 45(2), 123–134. https://doi.org/10.xxxx/abcd
All references should be accurate, complete, and relevant. Authors are responsible for ensuring the correctness of all cited sources.
4. Figures and Tables
Figures and tables must be of high resolution and submitted as separate files in JPG, PNG, or TIFF format. They should be clearly labeled (e.g., Figure 1, Table 1) and cited sequentially in the manuscript.
Each figure and table must have a concise yet descriptive title. Legends should explain all symbols, abbreviations, and units used. Graphs and charts must include axis labels, units, and statistical significance where applicable.
5. Submission Process
Authors must submit their manuscripts through the journal’s online submission portal. After registering and logging in, authors can upload the manuscript file along with all necessary supplementary materials, such as figures, tables, ethical approval letters, and data supplements.
Cover Letter
Every submission must be accompanied by a cover letter that includes:
The title of the manuscript
A brief overview of the research contribution
A statement confirming originality and that the manuscript is not under consideration elsewhere
Any declarations regarding prior publication, duplicate submissions, or previous rejections
6. Conflict of Interest
Authors must disclose any financial, professional, or personal relationships that may be perceived to influence the content of the manuscript. Conflicts of interest should be stated clearly in a dedicated section at the end of the manuscript.
7. Peer Review Process
All submissions will undergo double-blind peer review. Reviewers are selected based on their expertise in the manuscript’s subject area. The review process is designed to ensure scientific integrity, accuracy, and relevance.
Authors will receive constructive feedback and may be asked to revise their manuscript accordingly. The editorial board retains the final decision regarding acceptance.
8. Article Processing Charges
To support open-access publication and editorial processes, an Article Processing Charge (APC) will be applicable upon acceptance. Specific payment instructions and invoicing details will be provided to authors after their manuscript is accepted for publication.
9. Ethical Considerations
Research involving human subjects or animals must be conducted by relevant institutional and international ethical guidelines. Manuscripts must include:
The name of the ethics committee that approved the study
The approval number or reference ID
A statement that informed consent was obtained from all participants
For studies using previously published datasets or materials, proper permissions must be obtained and acknowledged.
10. Copyright and Licensing
Authors retain the copyright of their published work. Upon acceptance, authors grant the journal a license to publish the work under the Creative Commons Attribution (CC BY) license. This permits others to distribute and adapt the work, provided proper attribution is given to the original authors.
11. Revision and Resubmission
If revisions are required, authors must submit a revised manuscript along with a detailed response letter. This letter should address each reviewer comment individually and explain how the concerns were resolved. All changes should be highlighted in the revised document for transparency.